Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04605458 · ClinicalTrials.gov registry record · NA

Contingency Management to Promote Smoking Abstinence in Cancer Patients

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
282
Enrollment target

NCT04605458 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 282 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04605458, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
282 participants
Enrollment target

Study Summary

This is a smoking cessation treatment study. Patients who have a cancer or a suspected cancer who will undergo surgical removal of their cancer are eligible to participate in this study. A novel smoking cessation treatment will be provided to half of the participants in the study. All study participants will receive standard smoking cessation therapy including counseling and the nicotine patch.

Interventions

  • COMBINATION_PRODUCT Contingency Management
  • COMBINATION_PRODUCT Standard Care

Trial Details

FieldValue
Enrollment Target 282 participants
Start Date 2020-11-25
Est. Completion 2025-12-18
Phase NA

What the Registry Record Tells You About NCT04605458

The ClinicalTrials.gov registry entry for NCT04605458 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 282 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Contingency Management is the first listed.

NCT04605458 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04605458 about?

NCT04605458 is a clinical study titled "Contingency Management to Promote Smoking Abstinence in Cancer Patients". This is a smoking cessation treatment study. Patients who have a cancer or a suspected cancer who will undergo surgical removal of their cancer are eligible to participate in this study. A novel smoking cessation treatment will be provided to half of the participants in the study. All study particip...

What is the current status of trial NCT04605458?

This trial is currently completed. It is a NA study. The enrollment target is 282 participants. The study started on 2020-11-25. Estimated completion is 2025-12-18.

What interventions are being tested in trial NCT04605458?

The interventions under investigation include: Contingency Management (COMBINATION_PRODUCT), Standard Care (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT04605458?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.